Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add filters








Language
Year range
1.
China Pharmacy ; (12): 2561-2566, 2020.
Article in Chinese | WPRIM | ID: wpr-829588

ABSTRACT

OBJECTIVE:To put forward policy suggestions for the adjustment and reform of centralized drug procurement mode in China. METHODS :The evolution process of centralized drug procurement mode in China was reviewed ,and problems were found through literature research and expert interview. Combined with the experience of drug procurement platform construction,GPO procurement and medical insurance payment control fee management in the United States and Singapore ,the reform suggestions were put forward for basic model assumption of bidding procurement based on cost control target and drug bidding procurement policy. RESULTS & CONCLUSIONS :China’s drug bidding procurement system has gone through the stages of unified purchase and marketing ,decentralized procurement ,centralized procurement start-up and adjustment ,comprehensive implementation of online centralized drug procurement ,exploration of the integration of “two bidding ”(bidding for essential medicine and bidding for non-essential medicine )and joint procurement ,and pilot stage of national drug bidding and procurement. At the present stage ,there are many problems in centralized drug procurement ,such as the diversified subordination relationship of the platform ,the possible monopoly of enterprise selection under the policy of “two invoice system ”,price reduction becoming the core performance index of bidding procurement ,and the suspected monopoly operation of GPO procurement exploration. The model analysis based on the goal of cost control shows that drug cost is a function of efficiency ,drug quantity and price. High price leads to high cost ,while low efficiency leads to high cost. In the future ,the goal of drug bidding and procurement should not only foucs on price control ,but also on efficiency. The function of bidding and procurement will return to the essential function of “price for quantity ”. It is suggested that a relatively independent and unified platform should be established for drug bidding and procurement in China ,and the grouped procurement mode should be gradually standardized ,the expenditure control function of medical insurance payment audit should be exerted instead of simple price reduction ,and absolute unified lowest price procurement should be avoided.

2.
Article in Chinese | WPRIM | ID: wpr-756582

ABSTRACT

Public hospitals in China keep growing in terms of both scale and numbers, further misbalancing medical resources equity. Such expansion has brought about a series of challenges, and a consensus has been reached to maintain their development in a rational pace. To this end, both administrative interventions and market-based guidance should be used, including planning for regional healthcare and medical institutions as well as improving both institutional and market-based mechanisms to guide these hospitals toward a rational control of their scale.

3.
Article in Chinese | WPRIM | ID: wpr-667201

ABSTRACT

In line with the organizational theory, the authors described characteristics of management systems with conventional organizational structure,and those of enterprise management systems of special organizational forms. On such basis, the paper explored in depth the uniqueness of hospital management systems and cornerstone principles, thus proposed key points of modern hospital management system. In this study of systems for resource control, appraisal and incentive, the authors attempted to establish a balanced governance.

4.
Article in Chinese | WPRIM | ID: wpr-477416

ABSTRACT

Leveraging the centralized drug purchase platform of medical institutions in Beijing, the study measured the drug price index (DPI) and the DDD price index from 2005 to 2013, and the outcomes indicate a drop of both the drug price index and the drug price index calculated by DDD.Despite such drops however, drug price drop by itself could not curb the constant rise of drug expenses and medical costs due to changes in the structure and interval of drug administration.

5.
Article in Chinese | WPRIM | ID: wpr-477428

ABSTRACT

Objective To analyze the 2015 IAAF World Athletics Championships victim of disease type and composition,investigate medical emergency services for major international sporting events.Methods The 2015 IAAF World Athletics Championships in Medical Encounter Forms records in 737 cases during the game (2015-8-21 to 2015-8-30) were retrospectively reviewed and analyzed.Results Total of 737 patients during the match,trauma 259 cases (35.1%),respiratory diseases 196 cases (26.6%),digestive diseases 77 cases (10.4%),heat-related illnesses 41 cases (5.6%).Athletes 170 cases (23.1%),174 cases of staff (23.6%),139 cases of the IAAF family members (18.9%),136 cases of spectators (18.4%),members of the media 56 cases (7.6%).Conclusions 2015 IAAF World Athletics Championships type of disease the treatment of patients with the most common sports injury,followed by respiratory diseases and common diseases in summer heat-related illnesses.Clinic staff personnel structure the most common,followed by extended family members as well as the IAAF athletes and spectators.Major sports events should develop reasonable security programs for priority diseases and key customer base,and to ensure a smooth operation.

6.
Article in Chinese | WPRIM | ID: wpr-420280

ABSTRACT

Public hospitals reform is a key roadblock for the ongoing health reform.By means of such experiments as Three openings and three mechanisms,Beijing is practicing a separation of hospital regulation and management and separation of clinic and pharmacy,while building the mechanism of financial subscription for pricing,that of medical insurance adjustment,and that of hospital corporate governance.These measures aim at building a new management structure,operation mechanism and medical service model focusing on quality of care,efficiency and satisfaction.Separation of clinic and pharmacy has lowered drug proportion,average outpatient expense and out of-pocket payment of patients,as well as producing higher patient satisfaction,quality of care and hospital income.Other benefits include better management efficiency indirectly caused by separation of clinic and pharmacy,higher acceptance of the corporate governance,and service model innovation to better serve the people.

SELECTION OF CITATIONS
SEARCH DETAIL